Jenburkt Pharma launches COVID-19 drug at Rs 39 per tablet in India

Drug firm Jenburkt Pharmaceuticals on Friday said it has launched antiviral drug #Favipiravir under the brand name 'Favivent' for the treatment of mild to moderate #COVID19 symptoms at a price of Rs 39 per tablet.

Related Stories

No stories found.

X
The New Indian Express
www.newindianexpress.com